title: Docetaxel as second-line chemotherapy for non-small-cell lung cancer.
authors.forename: F
authors.initials: F
authors.lastname: Roila
authors.forename: A
authors.initials: A
authors.lastname: Del Favero
authors.forename: E
authors.initials: E
authors.lastname: Ballatori
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000077143:Docetaxel; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D015337:Multicenter Studies as Topic / Q000379:methods / Q000592:standards; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000592:standards; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel